In CLL cells isolated from the human and murine hosts we measured activation of BCR and NF-κB pathways, tumor proliferation, and the expression of immunophenotypic markers of cellular activation. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.